224 related articles for article (PubMed ID: 6334934)
1. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
Fedin IuV; Ermilova VD
Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
[TBL] [Abstract][Full Text] [Related]
2. [Functional activity of the regional lymph nodes in breast cancer patients].
Loboda VI; Grinevich IuA
Vopr Onkol; 1983; 29(2):31-6. PubMed ID: 6601329
[TBL] [Abstract][Full Text] [Related]
3. Quantitative morphologic assessment of immunoreactivity in regional lymph nodes of patients with carcinoma of the breast.
Wernicke M
Surg Gynecol Obstet; 1975 Jun; 140(6):919-24. PubMed ID: 1129683
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of axillary lymph node cells in patients with breast cancer.
Tsakraklides E; Tsakraklides V; Ashikari H; Rosen PP; Siegal FP; Robbins GF; Good RA
J Natl Cancer Inst; 1975 Mar; 54(3):549-56. PubMed ID: 1079055
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of the reaction of regional lymph nodes and lymphoid-cellular infiltration of the tumor in laryngeal cancer].
Ol'khovskaia IG; Matiakin EG
Vestn Otorinolaringol; 1992; (2):12-4. PubMed ID: 1632026
[TBL] [Abstract][Full Text] [Related]
7. [Changes in the lymphoid tissue of the axillary lymph nodes and the T-lymphocyte count of the blood of breast cancer patients].
Lavnikova GA; Ivinskaia NV; Eremina OF
Vopr Onkol; 1983; 29(2):43-6. PubMed ID: 6601330
[No Abstract] [Full Text] [Related]
8. [Lymphocytes of the blood, regional lymph nodes and tumor tissue in breast cancer].
Bazhenov SM; Dorosevich AE; Naperstnikov VV
Vopr Onkol; 1988; 34(9):1040-8. PubMed ID: 3055674
[No Abstract] [Full Text] [Related]
9. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
Pihl E; Nairn RC; Nind AP; Muller HK; Hughes ES; Cuthbertson AM; Rollo AJ
Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors.
Di Girolamo V; Laguens RP; Coronato S; Salas M; Spinelli O; Portiansky E; Laguens G
J Exp Clin Cancer Res; 2000 Jun; 19(2):155-9. PubMed ID: 10965811
[TBL] [Abstract][Full Text] [Related]
11. [Sinus histiocytosis of the regional lymph nodes as an indicator of antitumor resistance in breast cancer].
Loboda VI; Grinevich IuA
Arkh Patol; 1982; 44(10):45-9. PubMed ID: 7181708
[TBL] [Abstract][Full Text] [Related]
12. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
Ilyin NV; Dexter LI; Bochman YaV
Neoplasma; 1979; 26(4):423-7. PubMed ID: 392325
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of reactive changes in regional lymph nodes in gastric and mammary carcinomas.
Riegrová D; Jansa P
Neoplasma; 1982; 29(4):481-6. PubMed ID: 7133240
[TBL] [Abstract][Full Text] [Related]
14. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
Naik R; Baliga P; Bansal R; Pai M
J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
[TBL] [Abstract][Full Text] [Related]
15. Regional hyperplastic lymph nodes in breast cancer: the role of lymphocytes and nodal macrophages. An immunological study with a five-year follow-up.
Hickok DF; Miller L; Harris L
Surgery; 1977 Nov; 82(5):710-5. PubMed ID: 199957
[TBL] [Abstract][Full Text] [Related]
16. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
17. Stages of the development of immunologic response in regional lymph nodes draining breast cancer.
Kozlowski H; Hrabowska M
Neoplasma; 1978; 25(4):445-52. PubMed ID: 308619
[TBL] [Abstract][Full Text] [Related]
18. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
[TBL] [Abstract][Full Text] [Related]
19. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
Camp RL; Rimm EB; Rimm DL
Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
[TBL] [Abstract][Full Text] [Related]
20. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
